LBX(SH:603883) Shang Hai Zheng Quan Bao·2025-05-06 19:20Core Viewpoint - The announcement details a share reduction plan by the controlling shareholder of Lao Bai Xi Pharmacy Chain Co., Ltd., aimed at adjusting asset and financing structures while reducing stock pledge rates [2][4]. Group 1: Shareholder Information - As of the announcement date, the controlling shareholder, Lao Bai Xi Pharmaceutical Group Co., Ltd., holds 198,564,175 shares, accounting for 26.12% of the total share capital, while its concerted actor, Chen Xiulan, holds 13,565,698 shares, representing 1.78% of the total share capital [2][3]. Group 2: Reduction Plan Details - The pharmaceutical group plans to reduce its holdings by up to 22,802,868 shares, which is no more than 3% of the total share capital. This includes a maximum of 15,201,912 shares through block trading (up to 2% of total share capital) and up to 7,600,956 shares through centralized bidding (up to 1% of total share capital) [2][4]. - The reduction period is set for three months starting from 15 trading days after the announcement, excluding any periods where legal regulations prohibit share reductions [2][4]. Group 3: Previous Commitments - The pharmaceutical group has committed not to transfer or manage its shares acquired before the initial public offering for 36 months from the date of listing, with specific conditions for public offerings and compliance with relevant laws [5][6][7].